ONVO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ONVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-11), Organovo Holdings's current share price is $0.9695. Organovo Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $9.02. Organovo Holdings's Cyclically Adjusted PB Ratio for today is 0.11.
The historical rank and industry rank for Organovo Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Organovo Holdings's highest Cyclically Adjusted PB Ratio was 3.07. The lowest was 0.10. And the median was 0.35.
ONVO's Cyclically Adjusted PB Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Organovo Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $0.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.02 for the trailing ten years ended in Mar. 2024.
The historical data trend for Organovo Holdings's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 0.22 | 0.17 | 0.13 | 0.12 | 0.11 |
For the Biotechnology subindustry, Organovo Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Organovo Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Organovo Holdings's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Organovo Holdings's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 0.9695 | / | 9.02 | |
= | 0.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Organovo Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.357 | / | 131.7762 | * | 131.7762 | |
= | 0.357 |
Current CPI (Mar. 2024) = 131.7762.
Organovo Holdings Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 11.195 | 100.560 | 14.670 |
201409 | 13.290 | 100.428 | 17.438 |
201412 | 12.009 | 99.070 | 15.974 |
201503 | 11.945 | 99.621 | 15.801 |
201506 | 18.462 | 100.684 | 24.163 |
201509 | 16.496 | 100.392 | 21.653 |
201512 | 14.941 | 99.792 | 19.730 |
201603 | 13.460 | 100.470 | 17.654 |
201606 | 11.872 | 101.688 | 15.385 |
201609 | 11.197 | 101.861 | 14.485 |
201612 | 13.623 | 101.863 | 17.624 |
201703 | 11.929 | 102.862 | 15.282 |
201706 | 10.834 | 103.349 | 13.814 |
201709 | 9.739 | 104.136 | 12.324 |
201712 | 8.891 | 104.011 | 11.264 |
201803 | 8.031 | 105.290 | 10.051 |
201806 | 7.299 | 106.317 | 9.047 |
201809 | 6.748 | 106.507 | 8.349 |
201812 | 6.058 | 105.998 | 7.531 |
201903 | 5.854 | 107.251 | 7.193 |
201906 | 5.548 | 108.070 | 6.765 |
201909 | 4.765 | 108.329 | 5.796 |
201912 | 4.437 | 108.420 | 5.393 |
202003 | 4.080 | 108.902 | 4.937 |
202006 | 3.795 | 108.767 | 4.598 |
202009 | 2.969 | 109.815 | 3.563 |
202012 | 2.916 | 109.897 | 3.497 |
202103 | 4.521 | 111.754 | 5.331 |
202106 | 4.292 | 114.631 | 4.934 |
202109 | 3.945 | 115.734 | 4.492 |
202112 | 3.595 | 117.630 | 4.027 |
202203 | 3.468 | 121.301 | 3.767 |
202206 | 3.174 | 125.017 | 3.346 |
202209 | 2.870 | 125.227 | 3.020 |
202212 | 2.558 | 125.222 | 2.692 |
202303 | 1.759 | 127.348 | 1.820 |
202306 | 1.351 | 128.729 | 1.383 |
202309 | 0.970 | 129.860 | 0.984 |
202312 | 0.628 | 129.419 | 0.639 |
202403 | 0.357 | 131.776 | 0.357 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Organovo Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
David Gobel | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Vaidehi Joshi | director | C/O ORGANOVO HOLDINGS, INC., 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO CA 92121 |
Alison Tjosvold Milhous | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Adam K Stern | director | STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019 |
Thomas Hess | officer: President, CFO and PFO | 366 MADISON AVE. 12TH FLOOR, NEW YORK NY 10017 |
Douglas Jay Cohen | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Thomas E Jurgensen | officer: General Counsel & Secretary | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Jeffrey N. Miner | officer: Chief Scientific Officer | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Chris Heberlig | officer: President and CFO | C/O KINIKSA PHARMACEUTICALS, LTD., CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON D0 HM11 |
Keith Murphy | director, officer: Executive Chairman | 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
Steven George Hughes | officer: Chief Medical Officer | 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121 |
Carolyn Beaver | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
David Shapiro | director | C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013 |
Presnell Sharon Collins | officer: EVP, Research & Development | 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
Taylor Crouch | director, officer: CEO & President | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
From GuruFocus
By Business Wire Business Wire • 04-01-2020
By GuruFocusNews GuruFocusNews • 02-23-2022
By GuruFocusNews GuruFocusNews • 03-01-2022
By GuruFocusNews GuruFocusNews • 02-02-2022
By Business Wire Business Wire • 03-28-2020
By GuruFocusNews GuruFocusNews • 06-16-2022
By Marketwired Marketwired • 03-31-2020
By Marketwired • 09-08-2023
By Value_Insider Value_Insider • 11-15-2022
By GuruFocusNews GuruFocusNews • 05-17-2022